At-Home Blood Test Predicts Alzheimer's Risk in Minutes

Nearly a million people in the UK live with dementia, yet only one in 1,000 with early brain decline gets specialist care. That gap just got a simple solution.

Researchers at the University of Exeter unveiled an at-home test that predicts Alzheimer's risk using just a finger prick and an online quiz. People can now screen themselves from their living rooms, then mail their sample to labs for analysis.

The test hunts for two telltale proteins in blood: p-tau217 and GFAP. Scientists have linked these biomarkers to Alzheimer's disease and broader brain decline. When combined with online cognitive tests measuring memory and decision-making, the screening accurately flags people who need follow-up care.

The study tracked 174 people who administered the tests themselves at home. Results showed the combination worked as an effective "triage" system, sorting people by risk level and ensuring those most vulnerable get prioritized for diagnosis and treatment.

Professor Anne Corbett, who led the research, explained the significance. "This work raises the potential for screening people for their risk without the need for clinic visits or complex clinical assessments," she said. "It would ensure the people at highest risk could be prioritized for monitoring and diagnosis."

The Ripple Effect spreads far beyond convenience. Many people face real barriers to specialist clinics: transportation challenges, mobility issues, long wait times, or living in rural areas. This postal test removes those obstacles entirely, opening access to anyone with an internet connection and a mailbox.

The approach also eases pressure on overwhelmed healthcare systems. Instead of everyone with memory concerns flooding specialist clinics, the screening identifies who truly needs urgent attention. That means faster treatment for high-risk patients and better resource allocation for hospitals.

Dr. Sheona Scales from Alzheimer's Research UK called the innovation potentially revolutionary. "This kind of self-administered test could give reassurance to some people, while helping others move more quickly towards follow-up tests and support," she noted.

The research team now encourages adults over 40 to join their ongoing Protect study, which already includes 30,000 UK participants taking regular cognitive tests. Each volunteer helps researchers refine these tools and understand dementia's earliest warning signs.

Larger studies will confirm how the test performs across diverse populations and real-world settings, but the foundation looks solid: accessible screening that catches Alzheimer's early, when treatment works best.